XP Price Prediction Next Week
Analysis and Insights
To predict the stock price of XP Inc. (XP) for the next trading week, we analyze both technical indicators and recent news sentiment.
Technical Analysis:
- RSI (14-period): 78.44, indicating overbought conditions.
- MACD: A small positive signal, but the MACD line is close to the signal line, suggesting a potential crossover.
- Stochastic Oscillator: 63.28/41.12, moving downward from overbought territory.
- Fibonacci Levels: Support at 13.85 and resistance at 15.63.
Fundamental Analysis:
- Earnings Miss: XP reported $0.38 EPS, missing the consensus estimate of $1.39 by 72.66%.
- Revenue Beat: $767.81 million in revenue, surpassing expectations by 5.85%.
- Zacks Rank: Downgraded to #4 (Sell), indicating expected underperformance.
- Institutional Activity: Mixed sentiment, with 170 institutions increasing holdings and 185 reducing positions.
News Sentiment:
- Earnings Release: Negative sentiment due to the significant EPS miss.
- Rating Upgrade: Martin Zweig's strategy upgraded XP's rating from 62% to 85%, indicating strong interest in its fundamentals.
Price Prediction:
Based on the overbought RSI, bearish MACD crossover, and negative earnings surprise, XP is expected to decline. The next support level is at 13.85.
Prediction: XP stock will likely drop to $13.85 next week.
Recommendation: Sell XP stock at the current price of $15.405, targeting the support level of $13.85.
XP Similar Chart Price Prediction
The price of XP is predicted to go up -6.47%, based on the high correlation periods with HSY. The similarity of these two price pattern on the periods is 96.22%.
XP
HSY
Down: -6.47%Similarity: 96.22%
XP Revenue Forecast
XP EPS Forecast
XP FAQs
What is XP revenue forecast for next quarter？
What is XP eps forecast for next quarter？
XP Analyst's Forecast
Thiago Batista
UBS
Hold → Strong Buy
2025-01-24
Price Target
$19 → $16
Upside
+25.1%
UBS analyst Thiago Batista upgraded XP Inc. to Buy from Neutral with a price target of $16, down from $19. The firm believes the stock's valuation has more than incorporated the tough Brazilian macro assumptions. UBS views XP's recent strategy to expand into business-to-consumer positively, as thinks it could help XP control investment allocation and enhance the consumer experience. XP's potential change in distribution may improve its net margin over the long-term, even though the company tends to be more cyclical, the analyst tells investors in a research note.
Mario Pierry
B of A Securities
Strong Buy → Hold
2024-12-10
Price Target
$25 → $16
Upside
+23.74%
Jorge Kuri
Morgan Stanley
Hold
2024-11-26
Price Target
$24 → $21
Upside
+31%
